461
Views
121
CrossRef citations to date
0
Altmetric
Review

Perioperative hypertension management

&
Pages 615-627 | Published online: 06 Jun 2008

References

  • AcamporaGAMelendezJAKeefeDLIntraoperative administration of the intravenous angiotensin-converting enzyme inhibitor, enalaprilat, in a patient with congestive heart failureAnesth Analg19896983392556061
  • AdamsHAdamsRDel ZoppoGGuidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke AssociationStroke2005369162315800252
  • AdamsHPJrAdamsRJBrottTGuidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke AssociationStroke20033410568312677087
  • AlperACalhounDAntmanEMHypertensive emergenciesCardiovascular therapeutics : a companion to Braunwald’s Heart disease20022Philadelphia, PAW.B. Saunders Co
  • AnileCZanghiFBracaliASodium nitroprusside and intracranial pressureActa Neurochir (Wien)198158203117315551
  • AronsonSBoisvertDLappWIsolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgeryAnesth Analg20029410798411973166
  • AronsonSFontesMLMiaoYRisk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertensionCirculation20071157334217283267
  • AsiddaoCBDoneganJHWhitesellRCFactors associated with perioperative complications during carotid endarterectomyAnesth Analg19826163177201265
  • BaileyJMLuWLevyJHClevidipine in adult cardiac surgical patients: a dose-finding studyAnesthesiology20029610869411981147
  • BalserJRMartinezEAWintersBDBeta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmiasAnesthesiology199889105299821992
  • Bedford LaboratoriesFenoldopam Mesylate Injection USP prescribing information [online]2004 Accessed on July 16, 2007. URL: http://www.bedfordlabs.com/products/inserts/fenoldopam_pi.pdf
  • Bedford LaboratoriesLabetolol HCL Injection USP prescribing information [online]2000 Accessed on July 16, 2007. URL:http://www.bedfordlabs.com/products/inserts/LBTL-P02.pdf
  • BednarczykEMWhiteWBMungerMAComparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertensionAm J Cardiol19896399362564726
  • BergeKHLanierWLMyocardial infarction accompanying acute clonidine withdrawal in a patient without a history of ischemic coronary artery diseaseAnesth Analg199172259611985511
  • BodmannKFTrosterSClemensRHemodynamic profile of intravenous fenoldopam in patients with hypertensive crisisClin Investig199372604
  • BoldtJSchindlerEWollbruckMCardiorespiratory response of intravenous angiotensin-converting enzyme inhibitor enalaprilat in hypertensive cardiac surgery patientsJ Cardiothorac Vasc Anesth199594497718754
  • BorzeckiAMWongATHickeyECHypertension control: how well are we doing?Arch Intern Med200316327051114662624
  • BroderickJConnollySFeldmannEGuidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working GroupStroke20073820012317478736
  • BrownerWSLiJManganoDTIn-hospital and long-term mortality in male veterans following noncardiac surgery. The Study of Perioperative Ischemia Research GroupJAMA1992268228321608142
  • BurtVLCutlerJAHigginsMTrends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991Hypertension1995a266097607734
  • BurtVLWheltonPRoccellaEJPrevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991Hypertension1995b25305137875754
  • BussmannWDKenediPvon MengdenHJComparison of nitroglycerin with nifedipine in patients with hypertensive crisis or severe hypertensionClin Investig19927010858
  • CetnarowskiABContiDRNitroprusside toxicity and low-dose infusionAnn Intern Med198610489563706950
  • ChobanianAVBakrisGLBlackHRSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension2003a4212065214656957
  • ChobanianAVBakrisGLBlackHRThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA2003b28925607212748199
  • ColsonPRibsteinJMimranAEffect of angiotensin-converting enzyme inhibition on blood pressure and renal function during open heart surgeryAnesthesiology1990722372404429
  • CruiseCJSkrobikYWebsterREIntravenous labetalol versus sodium nitroprusside for treatment of hypertension postcoronary bypass surgeryAnesthesiology19897183592686494
  • CucchiaraRFBenefielDJMatteoRSEvaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomyAnesthesiology198665528312877599
  • DannenbergALGarrisonRJKannelWBIncidence of hypertension in the Framingham StudyAm J Public Health19887867693259405
  • DiPetteDJFerraroJCEvansRREnalaprilat, an intravenous angiotensin-converting enzyme inhibitor, in hypertensive crisesClin Pharmacol Ther1985381992042990798
  • DomenighettiGPerretCVariable hemodynamic response to sodium nitroprusside in hypertensive crisisIntensive Care Med19828187917119272
  • ElliottWJWeberRRNelsonKSRenal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertensionCirculation19908197071968368
  • EricssonHFaktCJolin-MellgardAClinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteersBr J Clin Pharmacol1999a47531810336577
  • EricssonHTholanderBRegardhCGIn vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and manEur J Pharm Sci1999b8293710072476
  • ErstadBLBarlettaJFTreatment of hypertension in the perioperative patientAnn Pharmacother200034667910669188
  • EstafanousFGTaraziRCSystemic arterial hypertension associated with cardiac surgeryAm J Cardiol198046685946774605
  • EstafanousFGTaraziRCViljoenJFSystemic hypertension following myocardial revascularizationAm Heart J19738573284540822
  • ForrestJBRehderKCahalanMKMulticenter study of general anesthesia. III. Predictors of severe perioperative adverse outcomesAnesthesiology1992763151729933
  • FriederichJAButterworthJFSodium nitroprusside: twenty years and countingAnesth Analg199581152627598246
  • FrohlichEDHypertension: evaluation and treatment1998Baltimore, MdWilliams and Wilkins
  • GalTJCoopermanLHHypertension in the immediate postoperative periodBr J Anaesth197547704238547
  • GarciaJYJrVidtDGCurrent management of hypertensive emergenciesDrugs1987346378
  • GerberJGNiesASGoodmanLSGilmanAGilmanAGAntihypertensive agents and the drug therapy of hypertensionGoodman and Gilman’s the pharmacological basis of therapeutics19908New YorkPergamon Pr
  • GibsonBEBlackSMaassLEsmolol for the control of hypertension after neurologic surgeryClin Pharmacol Ther19884465032904310
  • GirardDShulmanBJThysDMThe safety and efficacy of esmolol during myocardial revascularizationAnesthesiology198665157643526984
  • GobbelGTChanTYChanPHNitric oxide- and superoxide-mediated toxicity in cerebral endothelial cellsJ Pharmacol Exp Ther1997282160079316877
  • GoldbergMEClarkSJosephJNicardipine versus placebo for the treatment of postoperative hypertensionAm Heart J1990119446502301243
  • GoldbergMELarijaniGEPerioperative hypertensionPharmacotherapy199818911149758305
  • GoldmanLCalderaDLRisks of general anesthesia and elective operation in the hypertensive patientAnesthesiology19795028592434530
  • GoldmanLCalderaDLNussbaumSRMultifactorial index of cardiac risk in noncardiac surgical proceduresN Engl J Med197729784550904659
  • GrayRJManaging critically ill patients with esmolol. An ultra short-acting beta-adrenergic blockerChest1988933984032892647
  • GrayRJBatemanTMCzerLSUse of esmolol in hypertension after cardiac surgeryAm J Cardiol19855649F56F
  • GrayRJBatemanTMCzerLSComparison of esmolol and nitroprusside for acute post-cardiac surgical hypertensionAm J Cardiol198759887912881481
  • GriswoldWRReznikVMendozaSANitroprusside-induced intracranial hypertensionJAMA19812462679807310961
  • HajjarIKotchenTATrends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000JAMA200329019920612851274
  • HallVAGuestJMSodium nitroprusside-induced cyanide intoxication and prevention with sodium thiosulfate prophylaxisAm J Crit Care199211925 quiz 26–71307887
  • HalpernNAAliceaMKrakoffLRPostoperative hypertension: a prospective, placebo-controlled, randomized, double-blind trial, with intravenous nicardipine hydrochlorideAngiology19904199210042248428
  • HalpernNAGoldbergMNeelyCPostoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprussideCrit Care Med1992201637431458938
  • HartmannAButtingerCRommelTAlteration of intracranial pressure, cerebral blood flow, autoregulation and carbondioxide-reactivity by hypotensive agents in baboons with intracranial hypertensionNeurochirurgia (Stuttg)19893237432497395
  • HenriksenLPaulsonOBThe effects of sodium nitroprusside on cerebral blood flow and cerebral venous blood gases. II. Observations in awake man during successive blood pressure reductionEur J Clin Invest198212389936816609
  • HeropoulosMSchierenHSeltzerJLIntraoperative hemodynamic, renin, and catecholamine responses after prophylactic and intraoperative administration of intravenous enalaprilatAnesth Analg199580583907864430
  • HirschlMMBinderMBurAClinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crisesArch Intern Med19951552217237487244
  • HirschlMMBinderMBurAImpact of the renin-angiotensin-aldosterone system on blood pressure response to intravenous enalaprilat in patients with hypertensive crisesJ Hum Hypertens199711177839175570
  • HoustonMCAbrupt cessation of treatment in hypertension: consideration of clinical features, mechanisms, prevention and management of the discontinuation syndromeAm Heart J1981102415306115570
  • HowellSJSearYMYeatesDHypertension, admission blood pressure and perioperative cardiovascular riskAnaesthesia199651100048943587
  • HuntSAAbrahamWTChinMHACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm SocietyCirculation2005112e15423516160202
  • IzumiYBenzAMCliffordDBNeurotoxic effects of sodium nitroprusside in rat hippocampal slicesExp Neurol199312114238495709
  • JamesDJBedfordRFHydralazine for controlled hypotension during neurosurgical operationsAnesth Analg1982611016197149295
  • [JNC] Joint National Committee on Detection, Evaluation, and Treatment of High Blood PressureThe sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArch Intern Med19971572413469385294
  • [JNC] Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program; Coordinating CommitteeThe Seventh Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, JNC7 (Complete Report)2004Bethesda, Md., National Heart, LungBlood Institute, Health Information Center NIH Publication No. 04-5230
  • KantoJAllonenHKleimolaTPharmacokinetics of labetalol in healthy volunteersInt J Clin Pharmacol Ther Toxicol1981194147203731
  • KaplanJAClinical considerations for the use of intravenous nicardipine in the treatment of postoperative hypertensionAm Heart J199011944362405614
  • KaplanJAJonesELVasodilator therapy during coronary artery surgery. Comparison of nitroglycerin and nitroprussideJ Thorac Cardiovasc Surg1979773019105211
  • KearseLAJrRosowCZaslavskyABispectral analysis of the electroencephalogram predicts conscious processing of information during propofol sedation and hypnosisAnesthesiology19988825349447852
  • KhuriSFDaleyJHendersonWThe National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical careJ Am Coll Surg1995180519317749526
  • Kieler-JensenNJolin-MellgardANordlanderMCoronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgeryActa Anaesthesiol Scand2000441869310695913
  • KondoTBrockMBachHEffect of intra-arterial sodium nitroprusside on intracranial pressure and cerebral autoregulationJpn Heart J19842523176748223
  • KrossRAFerriELeungDA comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgeryAnesth Analg200091904911004045
  • LambertCRHillJAFeldmanRLEffects of nicardipine on left ventricular function and energetics in manInt J Cardiol198610237503957469
  • LambertCRHillJAFeldmanRLEffects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectorisAm J Cardiol19876047163630928
  • LambertCRHillJANicholsWWCoronary and systemic hemodynamic effects of nicardipineAm J Cardiol19855565263976506
  • LeslieJBristerNLevyJHTreatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprussideCirculation199490II256617955262
  • LevyJHThe ideal agent for perioperative hypertension and potential cytoprotective effectsActa Anaesthesiol Scand Suppl1993992058480502
  • LevyJHMancaoMYGitterRClevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: The results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1Anesth Analg20071059182517898366
  • LowenthalDTPorterRSSarisSDClinical pharmacology, pharmacodynamics and interactions with esmololAm J Cardiol19855614F18F
  • LuddenTMShepherdAMMcNayJLHydralazine kinetics in hypertensive patients after intravenous administrationClin Pharmacol Ther198028736427438689
  • Lund-JohansenPPharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalolDrugs198428Suppl 235506151890
  • ManganoDTBrownerWSHollenbergMAssociation of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research GroupN Engl J Med1990323178182247116
  • MannSJAtlasSALaraghJHBrennerBMHypertensive emergenciesHypertension: pathophysiology, diagnosis, and management19952New YorkRaven Pr
  • MannTCohnPFHolmanLBEffect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerinCirculation1978577328415825
  • MarxPGReidDSLabetalol infusion in acute myocardial infarction with systemic hypertensionBr J Clin Pharmacol19798233S238S526407
  • McKillionPCDellingerRPCivettaJMTaylorRWKirbyRRHypertensive emergencies and urgenciesCritical care19973PhiladelphiaLippincott-Raven
  • Merck and CoVasotec® I.V (enalaprilat) prescribing information [online]2000 Accessed on July 16, 2007. URL: http://www.fda.gov/cder/foi/label/2001/19309s23lbl.pdf
  • MeretojaOAAllonenHArolaMCombined alpha- and beta-blockade with labetalol in post-open heart surgery hypertension. Reversal of hemodynamic deterioration with glucagonChest198078810157004797
  • MorelDRForsterASuterPMI.V. labetalol in the treatment of hypertension following coronary-artery surgeryBr J Anaesth198254119167138722
  • MungerMARutherfordWFAndersonLAssessment of intravenous fenoldopam mesylate in the management of severe systemic hypertensionCrit Care Med19901850241970283
  • MurphyJDVaughanRSRosenMIntravenous enalaprilat and autonomic reflexes. The effects of enalaprilat on the cardiovascular responses to postural changes and tracheal intubationAnaesthesia198944816212556057
  • MurphyJMSageJITrimethaphan or nitroprusside in the setting of intracranial hypertensionClin Neuropharmacol198811436423064903
  • MuzziDABlackSLosassoTJLabetalol and esmolol in the control of hypertension after intracranial surgeryAnesth Analg19907068711967515
  • NakamuraYYasudaMFujimoriHCytotoxic effect of sodium nitroprusside on PC12 cellsChemosphere199734317249057300
  • NeusyAJLowensteinJBlood pressure and blood pressure variability following withdrawal of propranolol and clonidineJ Clin Pharmacol19892918242708545
  • NewsomeLRRothJVHugCCJrEsmolol attenuates hemodynamic responses during fentanyl-pancuronium anesthesia for aortocoronary bypass surgeryAnesth Analg19866545163485937
  • NiknahadHO’BrienPJInvolvement of nitric oxide in nitroprusside-induced hepatocyte cytotoxicityBiochem Pharmacol199651103198866825
  • NordlanderMBjorkmanJARegardHCPharmacokinetics and hemodynamic effects of an ultrashort-acting calcium antagonistBr J Anaesth199676A24
  • O’ConnorDEAccelerated acute clonidine withdrawal syndrome during coronary artery bypass surgery. A case reportBr J Anaesth19815343136971648
  • O’MalleyKSegalJLIsrailiZHDuration of hydralazine action in hypertensionClin Pharmacol Ther19751858161102235
  • OlsenKSSvendsenLBLarsenFSEffect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humansBr J Anaesth1995755147669469
  • Parke Davis Pharmaceuticals LtdNitrostat® (nitroglycerin tablets, USP) prescribing information [online]2000 Accessed on July 16, 2007. URL: http://www.pfizer.com/pfizer/download/uspi_nitrostat.pdf
  • PaschTSchulzVHoppelshauserGNitroprusside-induced formation of cyanide and its detoxication with thiosulfate during deliberate hypotensionJ Cardiovasc Pharmacol1983577856186864
  • PearceCJWallinJDLabetalol and other agents that block both alpha- and beta-adrenergic receptorsCleve Clin J Med1994615969 quiz 80–28124849
  • PlatiaEVMichelsonELPorterfieldJKEsmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutterAm J Cardiol19896392592564725
  • PletsCArterial hypertension in neurosurgical emergenciesAm J Cardiol19896340C42C2562817
  • PowersDRPapadakosPJWallinJDParenteral hydralazine revisitedJ Emerg Med19981619169543400
  • PowroznykAVVuylstekeANaughtonCComparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgeryEur J Anaesthesiol20032069770312974590
  • Prys-RobertsCGreeneLTMelocheRStudies of anaesthesia in relation to hypertension. II. Haemodynamic consequences of induction and endotracheal intubationBr J Anaesth197143531475089931
  • Prys-RrobertsCAnaesthesia and hypertensionBr J Anaesth198456711246145438
  • RauhalaPKhaldiAMohanakumarKPApparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprussideFree Radic Biol Med1998241065739626559
  • ReynoldsRDGorczynskiRJQuonCYPharmacology and pharmacokinetics of esmololJ Clin Pharmacol198626Suppl AA3A142870084
  • RobertsAJNiarchosAPSubramanianVASystemic hypertension associated with coronary artery bypass surgery. Predisposing factors, hemodynamic characteristics, humoral profile, and treatmentJ Thorac Cardiovasc Surg19777484659303728
  • RobinEDMcCauleyRNitroprusside-related cyanide poisoning. Time (long past due) for urgent, effective interventionsChest1992102184251446499
  • RodríguezGVaronJClevidipine: A Unique Agent for the Critical Care PractitionerCrit Care and Shock200693741
  • RosamondWFlegalKFridayGHeart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation2007115e6917117194875
  • RoseiEATrustPMBrownJJLetter: Intravenous labetalol in severe hypertensionLancet197521093453581
  • SchillingerDNifedipine in hypertensive emergencies: a prospective studyJ Emerg Med19875463733323299
  • SchmidtJFAndersenARPaulsonOBAngiotensin-converting enzyme inhibition, CBF autoregulation, and ICP in patients with normal-pressure hydrocephalusActa Neurochir (Wien)19901069122270793
  • SchroederHAEffects on hypertension of sulfhydryl and hydrazine compoundsJ Clin Invest19513067273
  • SegawaDSjoquistPOWangQDCalcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipineJ Cardiovasc Pharmacol2000363384310975591
  • SegawaDSjoquistPOWangQDTime-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part IIJ Cardiovasc Pharmacol2002403394512198319
  • ShepherdAMLuddenTMMcNayJLHydralazine kinetics after single and repeated oral dosesClin Pharmacol Ther198028804117438695
  • ShustermanNHElliottWJWhiteWBFenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal functionAm J Med19939516188102835
  • SmerlingAGersonyWMEsmolol for severe hypertension following repair of aortic coarctationCrit Care Med1990181288901977560
  • StephensCTJandhyalaBSEffects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized ratsClin Exp Hypertens2002243011312069360
  • StrakaRJLohrBBorchardt-PhelpsPIrwinRSCerraFBRippeJMAntihypertensive AgentsIntensive care medicine19963BostonLittle, Brown
  • StumpfJLDrug therapy of hypertensive crisesClin Pharm19887582913048849
  • TietjenCSHurnPDUlatowskiJATreatment modalities for hypertensive patients with intracranial pathology: options and risksCrit Care Med199624311228605807
  • TohmoHKarankoMEnalaprilat controls postoperative hypertension while maintaining cardiac function and systemic oxygenation after neurosurgeryIntensive Care Med19952165168522669
  • TowneJBBernhardVMThe relationship of postoperative hypertension to complications following carotid endarterectomySurgery198088575807423377
  • TumlinJADunbarLMOparilSFenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study GroupAcad Emerg Med200076536210905644
  • TurnerJMPowellDGibsonRMIntracranial pressure changes in neurosurgical patients during hypotension induced with sodium nitroprusside or trimetaphanBr J Anaesth19774941925861108
  • US National Center for Health StatisticsHealth, United States, 2005 with chartbook on trends in the health of Americans with special feature on drugs2005Hyattsville, Md, Washington, DCDept. of Health and Human Services, Centers for Disease Control and Prevention
  • van WezelHBKoolenJJVisserCAThe efficacy of nicardipine and nitroprusside in preventing poststernotomy hypertensionJ Cardiothorac Anesth1989370062521026
  • VaronJMarikPEThe diagnosis and management of hypertensive crisesChest20001182142710893382
  • VaronJMarikPEClinical review: the management of hypertensive crisesCrit Care200373748412974970
  • VaronJPeacockWGarrisonNProlonged infusion of clevidipine results in safe and predictable blood pressure control in patients with acute severe hypertensionChest20071324775
  • ViljoenJFEstafanousFGTaraziRCAcute hypertension immediately after coronary artery surgeryJ Thorac Cardiovasc Surg19767154850817089
  • VincentJLBerlotGPreiserJCIntravenous nicardipine in the treatment of postoperative arterial hypertensionJ Cardiothorac Vasc Anesth19971116049105985
  • WallinJDAdrenoreceptors and renal functionJ Clin Hypertens1985117182873207
  • WeberRRMcCoyCEZiemniakJAPharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patientsBr J Clin Pharmacol19882517212897206
  • WeissSJLongneckerDEPerioperative hypertension: an overviewCoron Artery Dis1993440168261215
  • [WHO] World Health OrganizationReducing risks, promoting healthy life. The world health report2002GenevaWorld Health Organization
  • WhiteWBHalleySEComparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertensionArch Intern Med198914987042565105
  • WhiteWBRadfordMJGonzalezFMSelective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopamJ Am Coll Cardiol1988111118232895780
  • WolfsthalSDIs blood pressure control necessary before surgery?Med Clin North Am199377349638441300
  • YatesAPHunterDNAnaesthesia and angiotensin-converting enzyme inhibitors. The effect of enalapril on peri-operative cardiovascular stabilityAnaesthesia19884393582850747